GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity ...

European shares were unchanged on Friday, as losses in heavyweight healthcare shares were countered by an advance in oil and ...

This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...

The British drugmaker was trying to revive the drug, which was pulled from U.S. markets in 2022 after failing a late-stage ...

US and European stock markets stalled or trimmed gains on Friday after a bullish week buoyed by US data and upbeat company ...

European and Asian stocks markets closed out the week broadly higher Friday following Wall Street's latest record highs ...

The FDA's ODAC voted that the benefit-risk profile of belantamab mafodotin in multiple myeloma were not favorable, ...

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

Many people think that Warren Buffet is a good lead indicator for financial markets, and Berkshire Hathaway has been offloading US banks in recent months. Many people may ask why sell stocks when they ...

U.S. stocks appear poised for a positive opening on Friday, as strong earnings from major companies throughout the week have ...

In a recent regulatory development, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs ...